BellRing Brands (BRBR) Stock Forecast & Price Target

$62.10

-0.16 (-0.26%)

(As of 10/9/2024 ET)

BellRing Brands - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy

Based on 14 Analyst Ratings

Sell
0

Hold
3

Buy
11

Based on 14 Wall Street analysts who have issued ratings for BellRing Brands in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 14 analysts, 3 have given a hold rating, and 11 have given a buy rating for BRBR.

Consensus Price Target

$62.64
0.87% Upside

According to the 14 analysts' twelve-month price targets for BellRing Brands, the average price target is $62.64. The highest price target for BRBR is $70.00, while the lowest price target for BRBR is $50.00. The average price target represents a forecasted upside of 0.87% from the current price of $62.10.

Get the Latest News and Ratings for BRBR and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for BellRing Brands and its competitors.

BRBR Analyst Ratings Over Time

Type	Current Forecast 10/10/23 to 10/9/24	1 Month Ago 9/10/23 to 9/9/24	3 Months Ago 7/12/23 to 7/11/24	1 Year Ago 10/10/22 to 10/10/23
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	11 Buy rating(s)	11 Buy rating(s)	10 Buy rating(s)	12 Buy rating(s)
Hold	3 Hold rating(s)	3 Hold rating(s)	3 Hold rating(s)	0 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$62.64	$62.64	$62.23	$40.62
Forecasted Upside	0.87% Upside	8.59% Upside	12.74% Upside	-3.07% Downside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Buy

$20 = Ounce of Gold? (Ad)

I've discovered a way to get exposure to MORE than an ounce of gold... for under $20. It's not bullion. It's not ETFs. And it's certainly not crypto.

Click here to find out why this is my favorite gold stock.

BRBR Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

BRBR Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

BellRing Brands Stock vs. The Competition

Type	BellRing Brands	Medical Companies	S&P 500
Consensus Rating Score	2.79	2.79	2.50
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy
Predicted Upside	0.70% Upside	11,054.21% Upside	7.26% Upside
News Sentiment Rating	Positive News See Recent BRBR News	Neutral News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
8/7/2024	JPMorgan Chase & Co. 3 of 5 stars		Lower Target	Overweight ➝ Overweight	$65.00 ➝ $64.00	+18.61%
8/6/2024	Stephens 4 of 5 stars		Reiterated Rating	Equal Weight ➝ Equal Weight	$55.00 ➝ $55.00	+0.02%
8/6/2024	Needham & Company LLC 2 of 5 stars		Reiterated Rating	Buy ➝ Buy	$66.00 ➝ $66.00	+33.85%
7/25/2024	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Buy ➝ Buy	$67.00 ➝ $65.00	+32.98%
5/9/2024	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$62.00 ➝ $65.00	+9.34%
5/8/2024	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$64.00 ➝ $70.00	+19.84%
Get the Latest News and Ratings for BRBR and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for BellRing Brands and its competitors with MarketBeat's FREE daily newsletter.
5/8/2024	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$60.00 ➝ $65.00	+12.03%
5/8/2024	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$63.00 ➝ $67.00	+13.44%
5/8/2024	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$60.00 ➝ $68.00	+16.36%
3/7/2024	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$61.00 ➝ $65.00	+5.30%
2/1/2024	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Buy	$67.00	+21.25%
1/3/2024	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Buy ➝ Hold	$55.00 ➝ $50.00	-8.54%
12/8/2023	DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Neutral	$60.00	+10.60%
10/17/2023	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$42.00 ➝ $50.00	+11.93%
4/28/2023	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target		$38.00 ➝ $42.00	+15.80%
4/26/2023	William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Andersen Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Outperform
2/8/2023	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy	$36.00 ➝ $42.00	+40.33%
12/14/2022	Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Outperform	$31.00	+23.41%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 12:20 AM ET.

BRBR Forecast - Frequently Asked Questions

: According to the research reports of 14 Wall Street equities research analysts, the average twelve-month stock price forecast for BellRing Brands is $62.64, with a high forecast of $70.00 and a low forecast of $50.00.
: 14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for BellRing Brands in the last twelve months. There are currently 3 hold ratings and 11 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" BRBR shares.
: According to analysts, BellRing Brands's stock has a predicted upside of 0.87% based on their 12-month stock forecasts.
: BellRing Brands has been rated by research analysts at Deutsche Bank Aktiengesellschaft, JPMorgan Chase & Co., Needham & Company LLC, and Stephens in the past 90 days.
: Analysts like BellRing Brands less than other "medical" companies. The consensus rating score for BellRing Brands is 2.79 while the average consensus rating score for "medical" companies is 2.79. Learn more on how BRBR compares to other companies.

Stock Forecasts and Research Tools

Related Companies:

Today's Ratings:

Top Rated Stocks:

More Ratings Tools:

War on Elon Escalates… (Ad)

Elon Musk, the guy slated to become the world’s first trillionaire by 2027, has publicly called for the adoption of this technology for decades. By doing so he has put himself in the crosshairs of an ideological war with the global elites. And yet, while this new technology threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.

Click here to learn how you can benefit from its widespread distribution.

This page (NYSE:BRBR) was last updated on 10/9/2024 by MarketBeat.com Staff

From Our Partners